Aromex 25 - Alpha Pharma

Exemestane, marketed under the brand name Aromasin®, is a potent steroidal aromatase inhibitor initially developed by Pharmacia & Upjohn and approved by the FDA in 1999 for the treatment of estrogen receptor-positive breast cancer in postmenopausal women. It works by irreversibly binding to the aromatase enzyme, reducing estrogen levels by approximately 85% in clinical studies. This suppression makes it effective in preventing gynecomastia and water retention during anabolic steroid cycles. Despite its efficacy, long-term use can potentially reduce bone mineral density and increase cardiovascular risks in men .

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Aromex 25 by Alpha Pharma, consult with your doctor or healthcare professional.